LOCUS       NP_000674                462 aa                     PRI 03-MAY-2014
DEFINITION  alpha-2C adrenergic receptor [Homo sapiens].
ACCESSION   NP_000674
VERSION     NP_000674.2  GI:71773208
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 462)
  AUTHORS   Aleong RG, Sauer WH, Robertson AD, Liggett SB and Bristow MR.
  TITLE     Adrenergic receptor polymorphisms and prevention of ventricular
            arrhythmias with bucindolol in patients with chronic heart failure
  JOURNAL   Circ Arrhythm Electrophysiol 6 (1), 137-143 (2013)
   PUBMED   23275278
  REMARK    GeneRIF: Bucindolol prevents ventricular arrhythmias in subjects
            with heart failure and reduced left ventricular ejection fractions,
            and this effect is modulated by adrenergic alpha 2 receptor
            polymorphisms.
REFERENCE   2  (residues 1 to 462)
  AUTHORS   Oh SH, Min KT, Jeon YJ, Kim MH, Kim OJ, Shin BS, Oh D and Kim NK.
  TITLE     Association between common genetic variants of alpha2A-, alpha2B-,
            and alpha2C-adrenergic receptors and ischemic stroke
  JOURNAL   Clin Neurol Neurosurg 115 (1), 26-31 (2013)
   PUBMED   22560155
  REMARK    GeneRIF: The ADRA2A and ADRA2C polymorphisms did not contribute to
            an increased risk of ischemic stroke or any pathophysiological
            subtype
REFERENCE   3  (residues 1 to 462)
  AUTHORS   Jahnsen JA and Uhlen S.
  TITLE     The predicted N-terminal signal sequence of the human
            alpha(2)C-adrenoceptor does not act as a functional cleavable signal
            peptide
  JOURNAL   Eur. J. Pharmacol. 684 (1-3), 51-58 (2012)
   PUBMED   22503931
  REMARK    GeneRIF: the predicted signal peptide in the N-terminal tail of the
            alpha(2C)-adrenoceptor does not act as a cleavable signal peptide
REFERENCE   4  (residues 1 to 462)
  AUTHORS   Savva J, Alfakih K, Galloway SL, Hall AS, West RM, Ball SG,
            Balmforth AJ and Maqbool A.
  TITLE     The alpha(2C)-Del322-325 adrenoceptor polymorphism and the
            occurrence of left ventricular hypertrophy in hypertensives
  JOURNAL   Blood Press. 21 (2), 116-121 (2012)
   PUBMED   22040172
  REMARK    GeneRIF: there is little evidence for an association between
            alpha(2C)Del322-325 polymorphism and an increased prevalence of left
            ventricular hypertrophy in patients with systemic hypertension.
REFERENCE   5  (residues 1 to 462)
  AUTHORS   Powe DG, Voss MJ, Habashy HO, Zanker KS, Green AR, Ellis IO and
            Entschladen F.
  TITLE     Alpha- and beta-adrenergic receptor (AR) protein expression is
            associated with poor clinical outcome in breast cancer: an
            immunohistochemical study
  JOURNAL   Breast Cancer Res. Treat. 130 (2), 457-463 (2011)
   PUBMED   21298476
  REMARK    GeneRIF: alpha1b and alpha2c AR is over-expressed in basal-like
            breast tumours of poor prognosis
REFERENCE   6  (residues 1 to 462)
  AUTHORS   Riess O, Thies U, Siedlaczck I, Potisek S, Graham R, Theilmann J,
            Grimm T, Epplen JT and Hayden MR.
  TITLE     Precise mapping of the brain alpha 2-adrenergic receptor gene within
            chromosome 4p16
  JOURNAL   Genomics 19 (2), 298-302 (1994)
   PUBMED   8188260
REFERENCE   7  (residues 1 to 462)
  AUTHORS   Eason MG and Liggett SB.
  TITLE     Human alpha 2-adrenergic receptor subtype distribution: widespread
            and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha
            2C2 mRNA in multiple tissues
  JOURNAL   Mol. Pharmacol. 44 (1), 70-75 (1993)
   PUBMED   7688069
REFERENCE   8  (residues 1 to 462)
  AUTHORS   Coupry I, Duzic E and Lanier SM.
  TITLE     Factors determining the specificity of signal transduction by
            guanine nucleotide-binding protein-coupled receptors. II.
            Preferential coupling of the alpha 2C-adrenergic receptor to the
            guanine nucleotide-binding protein, Go
  JOURNAL   J. Biol. Chem. 267 (14), 9852-9857 (1992)
   PUBMED   1349607
REFERENCE   9  (residues 1 to 462)
  AUTHORS   Chhajlani V, Rangel N, Uhlen S and Wikberg JE.
  TITLE     Identification of an additional gene belonging to the alpha 2
            adrenergic receptor family in the human genome by PCR
  JOURNAL   FEBS Lett. 280 (2), 241-244 (1991)
   PUBMED   1849485
REFERENCE   10  (residues 1 to 462)
  AUTHORS   Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ and
            Kobilka BK.
  TITLE     Cloning and expression of a human kidney cDNA for an alpha
            2-adrenergic receptor subtype
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 85 (17), 6301-6305 (1988)
   PUBMED   2842764
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC141928.2.
            This sequence is a reference standard in the RefSeqGene project.
            On or before Mar 4, 2006 this sequence version replaced
            gi:88978931, gi:4501967.
            Summary: Alpha-2-adrenergic receptors are members of the G
            protein-coupled receptor superfamily. They include 3 highly
            homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors
            have a critical role in regulating neurotransmitter release from
            sympathetic nerves and from adrenergic neurons in the central
            nervous system. The mouse studies revealed that both the alpha2A
            and alpha2C subtypes were required for normal presynaptic control
            of transmitter release from sympathetic nerves in the heart and
            from central noradrenergic neurons. The alpha2A subtype inhibited
            transmitter release at high stimulation frequencies, whereas the
            alpha2C subtype modulated neurotransmission at lower levels of
            nerve activity. This gene encodes the alpha2C subtype, which
            contains no introns in either its coding or untranslated sequences.
            [provided by RefSeq, Jul 2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript is intronless :: BC142625.1 [ECO:0000345]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..462
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="4"
                     /map="4p16"
     Protein         1..462
                     /note="alpha2-AR-C4; alpha-2C-adrenergic receptor;
                     alpha-2CAR; alpha-2C adrenoceptor; alpha-2C adrenoreceptor;
                     alpha-2 adrenergic receptor subtype C4; adrenergic,
                     alpha-2C-, receptor"
                     /product="alpha-2C adrenergic receptor"
                     /calculated_mol_wt="49391"
     Site            52..76
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          60..>184
                     /note="Serpentine type 7TM GPCR chemoreceptor Srx;
                     pfam10328"
                     /db_xref="CDD:255910"
                     /region_name="7TM_GPCR_Srx"
     Region          74..437
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            89..114
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            125..147
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            131
                     /note="Implicated in ligand binding (By similarity);
                     propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            169..191
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            208..231
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            214
                     /note="Implicated in catechol agonist binding and receptor
                     activation (By similarity); propagated from
                     UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            218
                     /note="Implicated in catechol agonist binding and receptor
                     activation (By similarity); propagated from
                     UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            380..407
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            421..441
                     /note="propagated from UniProtKB/Swiss-Prot (P18825.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..462
                     /coded_by="NM_000683.3:39..1427"
                     /gene="ADRA2C"
                     /gene_synonym="ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR"
                     /db_xref="CCDS:CCDS47004.1"
                     /db_xref="GeneID:152"
                     /db_xref="HGNC:HGNC:283"
                     /db_xref="MIM:104250"
ORIGIN
        1 maspalaaal avaaaagpna sgagergsgg vanasgaswg pprgqysaga vaglaavvgf
       61 livftvvgnv lvviavltsr alrapqnlfl vslasadilv atlvmpfsla nelmaywyfg
      121 qvwcgvylal dvlfctssiv hlcaisldry wsvtqaveyn lkrtprrvka tivavwlisa
      181 visfpplvsl yrqpdgaayp qcglndetwy ilsscigsff apclimglvy ariyrvaklr
      241 trtlsekrap vgpdgasptt englgaaaga genghcappp advepdessa aaerrrrrga
      301 lrrggrrrag aeggaggadg qgagpgaaes galtasrspg pggrlsrass rsvefflsrr
      361 rrarssvcrr kvaqarekrf tfvlavvmgv fvlcwfpfff syslygicre acqvpgplfk
      421 fffwigycns slnpviytvf nqdfrrsfkh ilfrrrrrgf rq
//
